Dr. William Schaffner offered his insights on the most recent COVID strain, HV.1, which belongs to the Omicron lineage.

Professor Schaffner, specializing in infectious diseases at the Vanderbilt University School of Medicine, issued a warning that the COVID strain HV.1 displays a high level of transmissibility. According to the Centers for Disease Control and Prevention (CDC), HV.1 has now become the prevailing strain in circulation across the United States.

Table of Contents

Watch Video Here

Professor Schaffner elaborated, stating, “In my general assessment, the descendants of Omicron, including HV.1, are generally highly transmissible.”

The Omicron variant is reported to be firmly established, although vigilance is essential. As vaccine-induced immunity wanes, there is an increased risk of hospitalization this winter for vulnerable groups who do not receive a COVID booster vaccine.

There is a possibility of a rise in COVID hospitalizations if susceptible populations do not receive vaccinations.

Professor Schaffner expressed concern that in the United States, there is the potential for a resurgence in hospitalizations. Nonetheless, there is some “reassuring” information from immunologists who suggest that the revised COVID vaccine should offer significant protection against severe illness.

Thus far, there is no evidence that HV.1 can evade the immunity provided by COVID vaccines, and it does not appear to cause more severe illness in comparison to other COVID strains.

High-risk populations are qualified to receive the autumn COVID booster shot.

Professor Schaffner stated to Verywell Health that we should anticipate ongoing mutation and the emergence of successive variants, each one following the others, leading to a mix of sub-variants.

See Also:   Live COVID-19 Updates: The Pirola variant spreading rapidly in the UK - one symptom to be aware of

As for COVID symptoms, they can encompass a wide range, with the NHS listing the following:

  • A high temperature or chills (a high temperature implies feeling hot to the touch on your chest or back, and you do not need to measure your temperature)
  • A new, persistent cough, characterized by prolonged bouts of coughing for over an hour or three or more episodes in a 24-hour period
  • A loss or alteration in your sense of smell or taste
  • Shortness of breath
  • Fatigue or exhaustion
  • Muscle aches
  • Headache
  • Sore throat
  • Stuffy or runny nose
  • Loss of appetite
  • Diarrhea
  • Nausea or vomiting

The majority of individuals experience an improvement in their condition within a few days to a few weeks after contracting COVID.

However, some individuals can continue to experience the effects of COVID for a period exceeding 12 weeks, a condition known as long COVID. Common manifestations of long COVID include:

  1. Profound fatigue
  2. Shortness of breath
  3. Loss of smell
  4. Muscle aches

Furthermore, additional symptoms associated with long COVID may involve:

  1. Cognitive difficulties and trouble with concentration, often referred to as “brain fog”
  2. Chest pain or a feeling of tightness in the chest
  3. Sleep disturbances, such as insomnia
  4. Heart palpitations
  5. Dizziness
  6. Pins and needles sensation
  7. Joint pain
  8. Depression and anxiety
  9. Tinnitus and earaches
  10. Nausea, diarrhea, stomach discomfort, and loss of appetite
  11. Elevated temperature, cough, headaches, sore throat, as well as alterations in the sense of smell or taste
  12. Skin rashes

 The report was presented by CHANELLE GEORGINA, a Senior Health Reporter based in London, specializing in health-related matters since 2020.
See Also:   "I'm a pharmacist - here's how to reduce your expenses on cold and cough remedies"

About the author

Getnice Olumide

Getnice Olumide (GetNice™) is an expert blogger, Forex Trader, Car Enthusiast, Web Developer, and Music Lyrics Synchronizer. Specializes in various blogs. I also love Technical Analysis for Swing or Day Trading in Forex—Love working on Car Reviews and their Performances, especially BMW. Google Knows More with the "Getnice Olumide" keyword.